BCIQ Profiles

Company Profile Report
0326 Reg QTs
BioCentury & Getty Images


March 26 Quick Takes: ADCs from Astellas-Seagen, Gilead under EMA review; plus Pfizer-Lilly, BrainStorm and Ilya

Mar 27, 2021 | 12:54 AM GMT

EMA to review Padcev for urothelial cancer
Astellas Pharma Inc. (Tokyo:4503) and Seagen Inc.

Read the full 395 word article

How to gain access

Continue reading with a
two-week free trial.